Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Maintains Neutral on Coty, Raises Price Target to $9

JP Morgan Maintains Neutral on Coty, Raises Price Target to $9

JP Morgan analyst Andrea Teixeira maintains Coty (NYSE:COTY) with a Neutral and raises the price target from $8 to $9.

byBenzinga Newsdesk

January 13, 2023

1 minute read

JP Morgan analyst Andrea Teixeira maintains Coty (NYSE:COTY) with a Neutral and raises the price target from $8 to $9.

Piper Sandler Downgrades Unity Software to Neutral, Lowers Price Target to $34

By Benzinga Newsdesk

July 14, 4:34 AM

Piper Sandler analyst Brent Bracelin downgrades Unity Software (NYSE:U) from Overweight to Neutral and lowers the price target from $55 to $34.

B of A Securities Downgrades Crescent Energy to Underperform, Raises Price Target to $14

By Benzinga Newsdesk

January 25, 8:17 AM

B of A Securities analyst John Abbott downgrades Crescent Energy (NYSE:CRGY) from Neutral to Underperform and raises the price target from $13 to $14.

CRGY

$2M Bet On Ford? Check Out These 4 Stocks Insiders Are Buying

By Avi Kapoor

December 12, 7:46 AM

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

What’s Going On With Botox Rival Revance Therapeutics’ Stock Today?

By Vandana Singh

September 19, 11:03 AM

Revance Therapeutics Inc (NASDAQ: RVNC) commenced a plan to exit the

RVNC

JP Morgan Maintains Neutral on Coty, Raises Price Target to $9

Related Posts

Piper Sandler Downgrades Unity Software to Neutral, Lowers Price Target to $34

B of A Securities Downgrades Crescent Energy to Underperform, Raises Price Target to $14

$2M Bet On Ford? Check Out These 4 Stocks Insiders Are Buying

What’s Going On With Botox Rival Revance Therapeutics’ Stock Today?